This startup develops a dialysis access port system designed to reduce infection, clotting, and pain for dialysis patients. Their platform offers improved vascular access for dialysis and other blood treatments, aiming to enhance the dialysis experience.
Funding
Funding not disclosed
Founders
Product
Problem
Hemodialysis patients often experience complications related to vascular access, including infections, clotting, and pain, which can negatively impact their quality of life and increase healthcare costs. Current dialysis access solutions may not adequately address these issues, leading to suboptimal patient outcomes.
Solution
Qubee Medical is developing a novel dialysis access port system designed to mitigate the common complications associated with hemodialysis. Their platform aims to improve vascular access for dialysis and other blood treatments by reducing the risk of infection and clotting, while also minimizing patient discomfort. By focusing on superior vascular access, Qubee Medical seeks to enhance the overall dialysis experience, leading to improved patient outcomes and a better quality of life. The company's mission is to address the costly challenges associated with dialysis and improve the patient experience.
Target Audience
The primary target audience includes hemodialysis patients, nephrologists, dialysis centers, and hospitals seeking to improve vascular access outcomes and enhance the patient experience during dialysis treatments.
Features
- Innovative dialysis access port design
- Focus on reducing infection rates
- Engineered to minimize clotting
- Designed for enhanced patient comfort
- Aims to improve blood flow rates during dialysis